Detalhe da pesquisa
1.
Identification and optimisation of a pyrimidopyridone series of IRAK4 inhibitors.
Bioorg Med Chem
; 63: 116729, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439688
2.
A brief diagnostic screen for cluster headache: Creation and initial validation of the Erwin Test for Cluster Headache.
Cephalalgia
; 41(13): 1298-1309, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34148408
3.
Cluster headache is one of the most intensely painful human conditions: Results from the International Cluster Headache Questionnaire.
Headache
; 61(1): 117-124, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33337540
4.
Cluster headache epidemiology including pediatric onset, sex, and ICHD criteria: Results from the International Cluster Headache Questionnaire.
Headache
; 61(10): 1511-1520, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34841518
5.
Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors.
Bioorg Med Chem
; 28(23): 115815, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33091850
6.
Effectiveness of Oxygen and Other Acute Treatments for Cluster Headache: Results From the Cluster Headache Questionnaire, an International Survey.
Headache
; 59(2): 235-249, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30632614
7.
Oxygen as the Optimal Acute Medication for Cluster Headache: A Comment and Additional Validation Step From the Cluster Headache Questionnaire.
Headache
; 60(10): 2592-2593, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32935343
8.
A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
Bioorg Med Chem Lett
; 18(2): 674-8, 2008 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18061446
9.
Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM Inhibitors.
ACS Med Chem Lett
; 9(8): 809-814, 2018 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30128072
10.
Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1 H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal Tumors.
J Med Chem
; 61(19): 8797-8810, 2018 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30204441
11.
AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and ESR1-Mutant Breast Tumors in Preclinical Models.
Cancer Res
; 76(11): 3307-18, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27020862
12.
Discovery of AZD3147: a potent, selective dual inhibitor of mTORC1 and mTORC2.
J Med Chem
; 58(5): 2326-49, 2015 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25643210
13.
Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist.
J Med Chem
; 58(20): 8128-40, 2015 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26407012
14.
Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases.
J Med Chem
; 56(5): 2059-73, 2013 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23394218
15.
16.
Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation.
J Med Chem
; 55(7): 3285-306, 2012 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22417091
17.
Development of a practical Buchwald-Hartwig amine arylation protocol using a conveniently prepared (NHC)Pd(R-allyl)Cl catalyst.
Org Biomol Chem
; 6(15): 2820-5, 2008 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-18633541
18.
Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
Bioorg Med Chem Lett
; 17(22): 6326-9, 2007 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17869514
19.
Inhibitors of epidermal growth factor receptor tyrosine kinase: optimisation of potency and in vivo pharmacokinetics.
Bioorg Med Chem Lett
; 16(18): 4908-12, 2006 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16806916